Chuck Royce's ORIC Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 979,664 shares of ORIC Pharmaceuticals, Inc. (ORIC) worth $10.61 M, representing 0.09% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 5 quarters.
Based on 13F filings, Chuck Royce has maintained this position in ORIC for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 1.22 M shares. Largest reduction occurred in Q1 2026, reducing 300,078 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's ORIC Pharmaceuticals (ORIC) Holding Value Over Time
Track share changes against reported price movement
Quarterly ORIC Pharmaceuticals (ORIC) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -227,559 | Reduce 18.85% | 979,664 | $10.83 |
| Q1 2026 | -300,078 | Reduce 19.91% | 1.21 M | $12.67 |
| Q4 2025 | +48,818 | Add 3.35% | 1.51 M | $8.18 |
| Q3 2025 | +1.22 M | Add 521.23% | 1.46 M | $12.00 |
| Q2 2025 | +234,774 | New Buy | 234,774 | $10.15 |
Chuck Royce's ORIC Pharmaceuticals Investment FAQs
Chuck Royce first purchased ORIC Pharmaceuticals, Inc. (ORIC) in Q2 2025, acquiring 234,774 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held ORIC Pharmaceuticals, Inc. (ORIC) for 5 quarters since Q2 2025.
Chuck Royce's largest addition to ORIC Pharmaceuticals, Inc. (ORIC) was in Q3 2025, adding 1,458,483 shares worth $17.5 M.
According to the latest 13F filing for Q2 2026, Chuck Royce's firm, Royce & Associates Lp, owns 979,664 shares of ORIC Pharmaceuticals, Inc. (ORIC), valued at approximately $10.61 M.
As of the Q2 2026 filing, ORIC Pharmaceuticals, Inc. (ORIC) represents approximately 0.09% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in ORIC Pharmaceuticals, Inc. (ORIC) was 1,507,301 shares, as reported at the end of Q4 2025.